Peter B. Heifetz
Directeur Général chez OrPro Therapeutics, Inc.
Profil
Peter B.
Heifetz is currently the President, Chief Executive Officer & Director at OrPro Therapeutics, Inc. and the Chief Scientific Officer at Rincon Pharmaceuticals, Inc. He holds graduate and doctorate degrees from Duke University.
Postes actifs de Peter B. Heifetz
| Sociétés | Poste | Début |
|---|---|---|
Rincon Pharmaceuticals, Inc.
 Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | - |
OrPro Therapeutics, Inc.
 OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Directeur Général | - |
Formation de Peter B. Heifetz
| Duke University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Rincon Pharmaceuticals, Inc.
Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Health Technology |
OrPro Therapeutics, Inc.
OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Health Technology |
